News Focus
News Focus
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: None

Wednesday, 04/02/2008 2:21:35 AM

Wednesday, April 02, 2008 2:21:35 AM

Post# of 1367
Kamada’s Intravenous AAT Hits
Primary Endpoint in Phase-3 Trial:
#msg-28121695.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now